Cancer Drug Encyclopedia

Adjuvant and neoadjuvant therapy for node-positive and high-risk early Breast Cancer.

First-line and second-line therapy for Metastatic Colorectal Cancer, Gastric Cancer, and Esophageal Adenocarcinoma.

First-line treatment of Metastatic Colorectal Cancer.

First-line treatment of KRAS/NRAS Wild-Type Metastatic Colorectal Cancer.

First-line treatment for Metastatic and Locally Advanced Pancreatic Adenocarcinoma, and advanced Colorectal Cancer.

Stage III Colon Cancer adjuvant therapy, Metastatic Colorectal Cancer, and Gastroesophageal Adenocarcinoma.

Colorectal Cancer, Gastric Cancer, and Pancreatic Cancer.

HER2-positive or HER2-low metastatic Breast Cancer, HER2-mutant Non-Small Cell Lung Cancer, and Gastric Adenocarcinoma.

HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.

HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.

Myelofibrosis, Polycythemia Vera, and acute/chronic Graft-versus-Host Disease (GVHD).

Adjuvant and metastatic treatment of postmenopausal women with Hormone Receptor-positive Breast Cancer.